Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management

Fig. 1

Proposed algorithm for clinical interpretation of a liquid biopsy for the detection of targetable mutations. For clinical interpretation, a targetable alteration found in a liquid biopsy is considered a true positive finding and is used to guide treatment selection. A liquid biopsy with no detectable alteration must be confirmed with a tissue biopsy to overcome false negative results

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us